Eperit Tablet (Eperisone Hydrochloride)

Adult dose

As Eperisone Hydrochloride, take 50 mg orally three times a day after meals. Adjust dosage appropriately based on age and symptoms.

This medication should not be used in certain patients. For instance, patients with an allergic reaction to this medication or those with myasthenia gravis should not be administered this medication. Additionally, since this medication contains lactose, it should not be used in patients with genetic disorders that cause lactose intolerance. Such disorders include galactose intolerance, Lapp lactase deficiency, and glucose-galactose malabsorption. Patients with a history of drug hypersensitivity or liver dysfunction should exercise caution when using this medication. Liver function may deteriorate, so their condition must be closely monitored. During the administration of this medication, rare severe allergic reactions, such as shock, may occur, so symptoms must be carefully observed. If signs of shock appear, administration should be stopped immediately, and appropriate treatment should be received. Since this medication can affect liver and kidney functions, if abnormal findings are found in liver enzyme levels or kidney function tests, administration should be stopped, and measures should be taken. Blood abnormalities, such as anemia, may develop, so symptoms should be monitored, and if any abnormalities appear, administration should be stopped. Hypersensitivity reactions, such as skin rashes or itching, may occur, and neurological symptoms such as insomnia, drowsiness, headaches, and limb paralysis have been reported. Gastrointestinal symptoms such as nausea, vomiting, loss of appetite, and abdominal pain may occur, so patients should inform if they experience any discomfort. Urological symptoms may include problems with urination or feelings of residual urine. Systemically, weakness, dizziness, and reduced muscle tone may occur, so caution is required. Symptoms such as toxic epidermal necrolysis, a serious skin abnormality reaction, may also appear, so symptoms such as fever, erythema, blisters, itching, eye congestion, and stomatitis should be closely monitored. If these symptoms appear, administration should be stopped immediately, and treatment should be initiated. Drowsiness or decreased concentration may occur during the administration of this medication, so it is advisable to avoid driving or operating hazardous machinery. Pregnant women or those who may become pregnant should only use this medication if the benefits outweigh the risks, as its safety has not been established. Breastfeeding women should avoid administration if possible or discontinue breastfeeding if administered. The safety in children has not been sufficiently confirmed, so caution should be exercised in their use. Elderly patients may have decreased physical function; therefore, caution such as reducing the dosage is necessary. Interactions causing disorders like visual accommodation have been reported when used with medications similar to this one, so caution should be taken when co-administering.

Serious side effects

Shock, liver abnormalities (increased ALT, AST, ALP), kidney abnormalities (proteinuria, increased BUN), anemia, anaphylaxis, angioedema, toxic epidermal necrolysis and mucocutaneous-eyes syndrome, severe allergic reactions, severe skin abnormal reactions

Mild side effects

• Rash
• itching
• insomnia
• drowsiness
• headache
• stiffness
• tremors
• nausea
• vomiting
• loss of appetite

This medication should be stored in a sealed container to prevent air exposure, at room temperature between 1°C and 30°C. Storing it this way will help maintain the drug's effectiveness for a longer period.

Appearance

White round coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle